Secondary axillary node carcinoma following treatment of Hodgkin's disease.
Fadia Elias
FE
Said
Paul
P
Shami
Bassem
B
Razzouk
Boutros
B
Soutou
Emile
E
Brihi
Walid
W
Salamoun
Georges
G
Aftimos
Michel
M
Saade
D000230:Adenocarcinoma / Q000175:diagnosis* / Q000188:drug therapy / Q000556:secondary; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001365:Axilla; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D003937:Diagnosis, Differential; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology*; D008466:Mechlorethamine / Q000008:administration & dosage; D009381:Neoplasms, Radiation-Induced / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011241:Prednisone